This module allows you to analyze existing cross correlation between DOW and BioShares Biotechnology Products. You can compare the effects of market volatilities on DOW and BioShares Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DOW with a short position of BioShares Biotechnology. See also your portfolio center. Please also check ongoing floating volatility patterns of DOW and BioShares Biotechnology.
|Time Horizon||30 Days Login to change|
Given the investment horizon of 30 days, DOW is expected to generate 0.4 times more return on investment than BioShares Biotechnology. However, DOW is 2.49 times less risky than BioShares Biotechnology. It trades about 0.66 of its potential returns per unit of risk. BioShares Biotechnology Products is currently generating about 0.12 per unit of risk. If you would invest 2,472,665 in DOW on December 20, 2017 and sell it today you would earn a total of 138,900 from holding DOW or generate 5.62% return on investment over 30 days.